One Level Deeper
Specialty chemicals ladder3 of 4 · finding 3 of 7
What's going on in specialty chemicals · 3 of 74/8

Quietly becoming CDMOs

Four talk like the sector next door. Four never say the word.

ACUTAAS ₹1,339 CR TODAY CDMO TARGET, FY28 ₹1,000 CR 75% OF TODAY’S WHOLE
Acutaas28
Navin21
Aether14
PI1
Aarti0
Deepak0
Guj Fluoro0
SRF0
“CDMO” or “CRAMS”, times said

Half this sector is describing itself in the language of the one next door. Acutaas says “CDMO” 28 times in a single call; Navin 21; Aether 14. Four companies never say it at all.

The sharpest instance: Acutaas has guided to ₹1,000 crore of CDMO revenue by FY28. Its entire revenue last year was ₹1,339 crore. A company filed under specialty chemicals is telling the market that contract manufacturing will be three-quarters of its present size within two years.

And it will not show you the number.

“We are not giving any split between the CDMO and non-CDMO in Pharma Intermediates space.” Abhishek Patel, President – Strategy · Acutaas Chemicals · 24 July 2026

The boundary between our two sector pages is thinner than either page implies.

Named in this finding
ShareWhatsAppLinkedInXEmail
Up a levelAll 7 findings — what’s going on in specialty chemicalsOne level deeperOne company, five questions — pick one it names
One level deeper · by email

Get the next one
by email

A sector, read end to end, and the companies as they are published. Roughly monthly. Nothing else, and one click to stop.

Not advice. Quotes are from the companies’ own earnings calls; figures from their filings.